PUBLIC CONTRACT · 2023

Medicamentos de Aquisição Centralizada

Contract value: €996,137.70
Signed on: 15 March 2023
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9890205

PUBLISHED DESCRIPTION

61003123 - AQ Urgente Medicamentos de Aquisição Centralizada

WHO CONTRACTED

Parties involved

Contracting body: Centro Hospitalar de Setúbal, E. P. E.
Awardee: GILEAD SCIENCES, LDA.; SPCARE ESPECIALIDADES FARMACEUTICAS, LDA; TECNIMEDE, SA; ASTRAZENECA - PROD.FARMACEUTICOS, LDA.; KEDRION PORTUGAL; KRKA FARMACEUTICA; CSL BEHRING; RB – PRODUTOS FARMACEUTICOS , LDA; MERCK SHARP DOHME; - - CLINIGEN HEALTHCARE LDA; NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA; FRESENIUS KABI PHARMA PORTUGAL, LDA.; CICLUM FARMA, UNIPESSOAL LDA.; DAIICHI SANKYO PORTUGAL UNIPESSOAL, LDA.; Octapharma-Prod Farmacêuticos, Lda; Sandoz; MEDINFAR-PROD FARMACEUTICO, S.; Generis Farmacêutica, SA; Pharmakern Portugal-Prod.Farmacêuticos Soc.Unip., Lda; JANSSEN CILAG FARMACEUTICA, LDA.; LAB. FARMACEUTICOS ROVI, SA.; Teva pHarma; DECOMED FARMACÊUTICA, S.A.; Boehringer Ingelheim Portugal; HIKMA FARMACÊUTICA (PORTUGAL) SA.; ORGANON PORTUGAL; LADORATORIO EDOL - PROD. FARMACÊUTICOS,S.A; CELGENE, SOCIEDADE UNIPESSOAL, LDA; EISAI FARMACÊUTICA, LDA; ACCORD HEALTHCARE , UNIPESSOAL LDA; ALEXION PHARMA SPAIN S L - SUCURSAL PORTUGAL; Bayer Portugal S.A.; Sanofi - Produtos Farmacêuticos, Lda; VIV HEALTHCARE, UNIPESSOAL, LDA; Laboratórios Pfizer, Lda; Baxter; Instituto Português do Sangue e da Transplantação, I. P.; MEDAC SUCURSAL PORTUGAL; BIOJAM, SA; LABORATÓRIOS ATRAL, S.A.; Pierre fabre medicament; Grifols Portugal-Produtos Farmacêuticos e Hospitalares, Lda.; Roche Sistemas de Diagnósticos, Lda; AMGEN - BIOFARMACÊUTICA, LDA.; MERCK SA; GLAXOSMITHKLINE-PROD. FARMACÊUTICOS, LDA.; MYLAN LDA; Biogen Portugal Sociedade Farmacêutica Unipessoal Lda.; ALLOGA PORTUGAL - ARMAZ. E DIST. FAR.(CANCELADA); AbbVie, Lda.
Place of performance: Portugal, Setúbal, Setúbal
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: GILEAD SCIENCES, LDA. · Tax ID 503604704
Awardee: SPCARE ESPECIALIDADES FARMACEUTICAS, LDA · Tax ID 508284872
Awardee: TECNIMEDE, SA · Tax ID 500626413
Awardee: ASTRAZENECA - PROD.FARMACEUTICOS, LDA. · Tax ID 502942240
Awardee: KEDRION PORTUGAL · Tax ID 508472830
Awardee: KRKA FARMACEUTICA · Tax ID 507981227
Awardee: CSL BEHRING · Tax ID 503047201
Awardee: RB – PRODUTOS FARMACEUTICOS , LDA · Tax ID 510784429
Awardee: MERCK SHARP DOHME · Tax ID 500191360
Awardee: - - CLINIGEN HEALTHCARE LDA
Awardee: NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA · Tax ID 500063524
Awardee: FRESENIUS KABI PHARMA PORTUGAL, LDA. · Tax ID 504293753
Awardee: CICLUM FARMA, UNIPESSOAL LDA. · Tax ID 504362674
Awardee: DAIICHI SANKYO PORTUGAL UNIPESSOAL, LDA. · Tax ID 501509860
Awardee: Octapharma-Prod Farmacêuticos, Lda · Tax ID 502820780
Awardee: Sandoz · Tax ID 506985261
Awardee: MEDINFAR-PROD FARMACEUTICO, S. · Tax ID 500384045
Awardee: Generis Farmacêutica, SA · Tax ID 508107997
Awardee: Pharmakern Portugal-Prod.Farmacêuticos Soc.Unip., Lda · Tax ID 507002571
Awardee: JANSSEN CILAG FARMACEUTICA, LDA. · Tax ID 500189412
Awardee: LAB. FARMACEUTICOS ROVI, SA. · Tax ID 980166705
Awardee: Teva pHarma · Tax ID 507045491
Awardee: DECOMED FARMACÊUTICA, S.A. · Tax ID 503099660
Awardee: Boehringer Ingelheim Portugal · Tax ID 500537410
Awardee: HIKMA FARMACÊUTICA (PORTUGAL) SA. · Tax ID 502266791
Awardee: ORGANON PORTUGAL · Tax ID 500208131
Awardee: LADORATORIO EDOL - PROD. FARMACÊUTICOS,S.A · Tax ID 507072642
Awardee: CELGENE, SOCIEDADE UNIPESSOAL, LDA · Tax ID 507791690
Awardee: EISAI FARMACÊUTICA, LDA · Tax ID 507847660
Awardee: ACCORD HEALTHCARE , UNIPESSOAL LDA · Tax ID 508622263
Awardee: ALEXION PHARMA SPAIN S L - SUCURSAL PORTUGAL · Tax ID 980553768
Awardee: Bayer Portugal S.A. · Tax ID 500043256
Awardee: Sanofi - Produtos Farmacêuticos, Lda · Tax ID 500134960
Awardee: VIV HEALTHCARE, UNIPESSOAL, LDA · Tax ID 509117961
Awardee: Laboratórios Pfizer, Lda · Tax ID 500162166
Awardee: Baxter · Tax ID 503347345
Awardee: Instituto Português do Sangue e da Transplantação, I. P. · Tax ID 502423943
Awardee: MEDAC SUCURSAL PORTUGAL · Tax ID 980369959
Awardee: BIOJAM, SA · Tax ID 513642749
Awardee: LABORATÓRIOS ATRAL, S.A. · Tax ID 500162085
Awardee: Pierre fabre medicament · Tax ID 500230366
Awardee: Grifols Portugal-Produtos Farmacêuticos e Hospitalares, Lda. · Tax ID 502041285
Awardee: Roche Sistemas de Diagnósticos, Lda · Tax ID 504282921
Awardee: AMGEN - BIOFARMACÊUTICA, LDA. · Tax ID 502942959
Awardee: MERCK SA · Tax ID 500650870
Awardee: GLAXOSMITHKLINE-PROD. FARMACÊUTICOS, LDA. · Tax ID 500139962
Awardee: MYLAN LDA · Tax ID 502248793
Awardee: Biogen Portugal Sociedade Farmacêutica Unipessoal Lda. · Tax ID 506415740
Awardee: ALLOGA PORTUGAL - ARMAZ. E DIST. FAR.(CANCELADA) · Tax ID 504507230
Awardee: AbbVie, Lda. · Tax ID 510229050

Matches in the records

MYLAN LDA and CSL BEHRING share an address · Source: TED (Jornal Oficial da UE), aviso 637400-2025 · Source: TED (Jornal Oficial da UE), aviso 604352-2025

Address and group matches come from the records cited and say only what those records show.

HOW MUCH AND WHEN

Values and timeline

Contract price: €996,137.70
Procedure base price: €996,137.70
Total effective price: Not reported on Portal BASE
Publication date: 27 March 2023
Award date: 15 March 2023
Signing date: 15 March 2023
Performance period: 12 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Monofator
CPV code: 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
Legal basis: Artigo 32.º, n.º 2 do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: CP 2022/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 6416554

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts